MAP Pharmaceuticals Inc., of Mountain View, Calif., named Charlene A. Friedman vice president, general counsel and secretary.

Med BioGene Inc., of Vancouver, British Columbia, appointed Nathan Yoganathan chief scientific advisor and appointed Bradley McLean chief scientific officer.

Neogen Corp., of Lansing, Mich., appointed Clayton K. Yeutter to its board of directors.

NeurAxon Inc., of Waltham, Mass., named Lawrence E. Bloch chief executive officer and appointed him to its board of directors.

Nventa Biopharmaceuticals Corp., of San Diego, named Ian Hector Frazer, W. Martin Kast, Myron J. Levin, Jeffrey Weber and T.C. Wu to its clinical and scientific advisory board.

OxiGene Inc., of Waltham, Mass., appointed Patricia Walicke chief medical officer and vice president.

Pathway Medical, of Redmond, Wash., named Paul Buckman to its board of directors and John Yaholkovsky vice president of manufacturing.

Peregrine Pharmaceuticals Inc., of Tustin, Calif., appointed Mary J. Boyd head of business development for Asia and Europe.

Phytomedics Inc., of Jamesburg, N.J., named Arthur H. Finnel chief financial officer.

Reliant Pharmaceuticals Inc., of Liberty Corner, N.J., appointed Fred Craves chairman of its board of directors.

XOMA Ltd., of Berkeley, Calif., elected Charles J. Fisher to its board of directors.